Literature DB >> 33067054

Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples.

Sagnik Bhattacharyya1, Tabea Schoeler2, Rashmi Patel3, Marta di Forti3, Robin M Murray3, Philip McGuire3.   

Abstract

BACKGROUND: Although most patients with psychotic disorders experience relapse, it is not possible to predict whether or when an individual patient is going to relapse. We aimed to develop a multifactorial risk prediction algorithm for predicting risk of relapse in first episode psychosis (FEP).
METHODS: Data from two prospectively collected cohorts of FEP patients (N = 1803) were used to develop three multiple logistic prediction models to predict risk of relapse (defined as hospitalization) within the first 2 years of onset of psychosis. Model 1 (M1S1) used data obtained from clinical notes (Sample 1) while model 2 (M2S2) applied the same set of predictors using data obtained from research interviews (Sample 2). The final model (Sample 2: M3S2) used the same predictors plus additional detailed information on predictors. Model performance was evaluated employing measures of overall accuracy, calibration, discrimination and internal validation.
RESULTS: In both samples, the 2-year probability of psychiatric hospitalization was 37%. Of all the models, discrimination accuracy was lowest when limited information (such as socio-demographic and clinical parameters) was included in the prediction model. Model M3S2 using additional information (descriptors of pattern of cannabis, nicotine, alcohol and other illicit drug use) obtained from research interview had the best discrimination accuracy (Harrell's C index 0.749).
CONCLUSIONS: The measures that contributed most to predicting hospitalization are readily accessible in routine clinical practice, suggesting that a risk prediction tool based on these models would be clinically practicable following validation in independent samples and permit a personalized approach to relapse prevention in psychosis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hospitalization; Model development; Psychosis; Relapse; Risk prediction

Year:  2020        PMID: 33067054     DOI: 10.1016/j.schres.2020.09.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.

Authors:  Rashmi Patel; Soon Nan Wee; Rajagopalan Ramaswamy; Simran Thadani; Jesisca Tandi; Ruchir Garg; Nathan Calvanese; Matthew Valko; A John Rush; Miguel E Rentería; Joydeep Sarkar; Scott H Kollins
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006

Review 2.  Prediction models in first-episode psychosis: systematic review and critical appraisal.

Authors:  Rebecca Lee; Samuel P Leighton; Lucretia Thomas; Georgios V Gkoutos; Stephen J Wood; Sarah-Jane H Fenton; Fani Deligianni; Jonathan Cavanagh; Pavan K Mallikarjun
Journal:  Br J Psychiatry       Date:  2022-01-24       Impact factor: 10.671

3.  Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis.

Authors:  Nora Penzel; Rachele Sanfelici; Linda A Antonucci; Linda T Betz; Dominic Dwyer; Anne Ruef; Kang Ik K Cho; Paul Cumming; Oliver Pogarell; Oliver Howes; Peter Falkai; Rachel Upthegrove; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Frauke Schultze-Lutter; Marlene Rosen; Theresa Lichtenstein; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo K R Salokangas; Christos Pantelis; Stephen J Wood; Boris B Quednow; Giulio Pergola; Alessandro Bertolino; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-09

4.  Advances in Using MRI to Estimate the Risk of Future Outcomes in Mental Health - Are We Getting There?

Authors:  Aleix Solanes; Joaquim Radua
Journal:  Front Psychiatry       Date:  2022-04-12       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.